Blinatumomab-induced T cell activation at single cell transcriptome resolution.

BLOOD(2021)

引用 11|浏览11
暂无评分
摘要
These results reveal a target cell-dependent mechanism of T-cell activation by blinatumomab and suggest that TNFSF4 may be responsible for the resistant mechanism and a potential target for combination therapy with blinatumomab, to treat B-ALL or other B-cell malignancies.
更多
查看译文
关键词
Acute B cell lymphoblastic leukemia,Bi-specific T-cell engager antibody,Blinatumomab,Single-cell RNA-Seq,T cell activation,TNFRSF4
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要